Fig. 1From: Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemiaAttainment of guideline-recommended RAASi dose in (a) the US and (b) Japan. HK hyperkalemia, mo month, RAASi renin-angiotensin-aldosterone system inhibitorBack to article page